Pharmascience
Pharmascience is a Canada-based pharmaceutical company that develops and commercializes generic drugs and over-the-counter products for the healthcare industry.
Business Model:
Revenue: $585M
Employees: 1,001-5,000
Rankings
Industries / Tags:
Detailed Pharmascience Information
Geographic Data
Address: 6111 Royalmount Avenue
City: Montreal
State: quebec
Zip: H4P 2T4
Country: CA
Financial Info
Stage:
debt financing
Raised Last:
$4M
Raised Total:$4M
Social
Metrics
2,546,933Website Global Rank
7,026Website Monthly Traffic
Twitter Followers
Description
Pharmascience is a Canada-based pharmaceutical company that develops and commercializes generic drugs and over-the-counter products for the healthcare industry.
Contact Phone:
+15143409800
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 11/2017 | RDD Pharma | Series B | 0 |
| 9/2017 | Edesa Biotech | Series A | 7M |
| 9/2017 | Stellar Biotechnologies | Post-IPO Equity | 0 |
| 2/2015 | BionPharma | Venture Round | 0 |
| 9/2016 | Pharmaceutics International | Private Equity Round | 0 |
| 11/2017 | RDD Pharma | Series B | 0 |
| 9/2017 | Stellar Biotechnologies | Post-IPO Equity | 0 |
| 9/2017 | Edesa Biotech | Series A | 0 |
| 9/2016 | Pharmaceutics International | Private Equity Round | 0 |
| 2/2015 | BionPharma | Venture Round | 0 |
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 5/2011 | Debt Financing | 1 | $3.5M |
Government of Canada Government of Canada Government of Canada Government of Canada |
|---|
| Announced Date | Name | Price |
|---|---|---|
| 5/2011 | Aegera Therapeutics |
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
